Hyaluronic acid sodium (MW 5000)
Based on 1 Customer Validation
Hyaluronic acid (sodium) (MW 5000) is a biopolymer composed of repeating disaccharide units with a molecular weight of 5000. Hyaluronic acid (sodium) (MW 5000) can be used for dry-eye syndrome research.
For research use only. We do not sell to patients.
- CAS No.: 9067-32-7
- Molecular Weight:5000 (Average)
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
HY-B0633I
Hyaluronic acid sodium (MW 800kDa) -
HY-B0633D
Hyaluronic acid sodium (MW 200-1560) -
HY-B0633C
Hyaluronic acid (Mw:1000-2000Da) -
HY-B0633
Hyaluronic acid sodium -
HY-B0633P
Hyaluronic acid sodium (MW 0.9M-1.0Mda) -
HY-B0633A
Hyaluronic acid -
HY-B0633B
Hyaluronic acid (MW 50000-100000) -
HY-B0633E
Hyaluronic acid, low endotoxin -
HY-113511
Glycogen, Mussel -
HY-113511C
Glycogen, from bovine liver, ≥85% -
HY-113511A
Glycogen, Oysters -
HY-113511B
Glycogen, from rabbit liver, ≥85%
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
In Vitro
Hyaluronic acid (HA) is widely used in aesthetic medicine due to its binding ability with a large number of water molecules. It improves tissue hydration and their resistance to mechanical damage. HA plays an important role in wound healing, ovulation, fertilization, signal transduction, and tumor physiology. HA is used in joint diseases such as osteoarthritis or rheumatoid arthritis. HA of a high molecular mass reduces the chemotaxis and migration of inflammatory cells which acts as a good barrier to the inflammatory process and protects against the effects of free radicals. HA is used in ophthalmology due to its lubricating properties for the corneal endothelium, and improves tissue hydration and cellular resistance to mechanical damage in aesthetic dermatology, and has marginal adverse effects. Several trials indicate its role in tumor markers, liver diseases, and in pharmaceuticals[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 9067-32-7
-
Appearance Solid
-
Molecular Weight 5000 (Average)
-
Color White to off-white
-
SMILES
CO[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@@H]([C@H]([C@@H](O[C@H]2C(O[Na])=O)OC)O)O)[C@@H]1NC(C)=O.[n]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
H2O : 50 mg/mL (Need ultrasonic)
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Snetkov P, et al. Hyaluronic Acid: The Influence of Molecular Weight on Structural, Physical, Physico-Chemical, and Degradable Properties of Biopolymer. Polymers (Basel). 2020 Aug 11;12(8):1800. [Content Brief]
[2]. Nepp J, et al. The clinical use of viscoelastic artificial tears and sodium chloride in dry-eye syndrome. Biomaterials. 2001 Dec;22(24):3305-10. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Hyaluronic acid sodium (MW 5000) Related Classifications
HY-B0633O Related Classifications
Powered by Bioz